These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Joint hypermobility syndrome and bilateral total occlusion of the ulnar arteries presenting as Raynaud's phenomenon. Haberhauer G; Feyertag J; Hanusch-Enserer U; Dunky A Clin Exp Rheumatol; 2000; 18(2):270-1. PubMed ID: 10812513 [No Abstract] [Full Text] [Related]
10. Raynaud's Syndrome: a neglected disease. Poredos P; Poredos P Int Angiol; 2016 Apr; 35(2):117-21. PubMed ID: 25673314 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of Raynaud's phenomenon]. Guilmot JL; Diot E; Lasfargues G Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1755-60. PubMed ID: 1685081 [TBL] [Abstract][Full Text] [Related]
12. Is iloprost effective in secondary Raynaud's phenomenon? Lustig N; Rada G Medwave; 2015 Mar; 15(2):e6082. PubMed ID: 25826330 [TBL] [Abstract][Full Text] [Related]
13. Recent achievements in the management of Raynaud's phenomenon. Baumhäkel M; Böhm M Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628 [TBL] [Abstract][Full Text] [Related]
14. [Management of Raynaud's phenomenon]. Boccalon H; Monin A; Reggy M Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023 [No Abstract] [Full Text] [Related]